Back to Search
MARY LIST, MD
MD
Dermatology Physician
NPI: 1013440874IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
35.148704(OH)
CMS Specialties
PrimaryDERMATOLOGY
Education
OTHER
Class of 2019
Research & Publications (20)
Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients.
PMID 14762885·Head Neck·2004
4-observational
Quality of life and late toxicities in head and neck cancer.
PMID 12619549·Cancer Treat Res·2003
6-review
An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neck.
PMID 12115322·Cancer·2002
8-other
Evaluation of quality of life in patients definitively treated for squamous carcinoma of the head and neck.
PMID 10841193·Curr Opin Oncol·2000
6-review
How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?
PMID 10673531·J Clin Oncol·2000
4-observational
Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
PMID 18936351·Arch Otolaryngol Head Neck Surg·2008
8-other
Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804.
PMID 18314912·Psychooncology·2008
4-observational
A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores.
PMID 17922221·Qual Life Res·2007
2-rct
Complementary and alternative medicine use among breast cancer survivors.
PMID 17604560·J Altern Complement Med·2007
8-other
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
PMID 16849759·J Clin Oncol·2006
3-trial
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.
PMID 16832122·J Clin Oncol·2006
6-review
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
PMID 16596230·Int J Oncol·2006
3-trial
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
PMID 16322304·Clin Cancer Res·2005
3-trial
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).
PMID 15625373·J Clin Oncol·2005
3-trial
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
PMID 14676118·Clin Cancer Res·2003
8-other
Is patient travel distance associated with survival on phase II clinical trials in oncology?
PMID 13130112·J Natl Cancer Inst·2003
8-other
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
PMID 12738722·Clin Cancer Res·2003
3-trial
Educating African-American men about prostate cancer: impact on awareness and knowledge.
PMID 12597936·Urology·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 2139 AUBURN AVE
CINCINNATI, OH 45219 - Phone
- (513) 585-0855
Quick Facts
- NPI
- 1013440874
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile